Value of direct-to-consumer drug advertising oversold, study finds

Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.

Read the whole article on Physorg

More from Physorg